Market Overview

UPDATE: Stifel Upgrades Brooks Automation As Life Sciences Are Key To Growth

Share:
Related BRKS
51 Biggest Movers From Yesterday
Mid-Afternoon Market Update: Dow Falls Over 200 Points; Otonomy Shares Spike Higher

In a report published Friday, Stifel analyst Patrick Ho upgraded the rating on Brooks Automation (NASDAQ: BRKS) from Hold to Buy, and named a $13.00 price target.

In the report, Stifel noted, “We are upgrading shares of Brooks Automation from a Hold to a Buy rating and establishing a $13 target price, which we believe reflects a sum-of-parts valuation analysis over the next few years. We are now comfortable with the company's growth prospects in its emerging life sciences business and as we have cited previously, we believe the growth in this area will be the key driver in the overall company's fortunes and the appreciation potential in the stock.”

Brooks Automation closed on Thursday at $9.92.

Latest Ratings for BRKS

DateFirmActionFromTo
Nov 2017CitigroupMaintainsBuy
Nov 2017Stifel NicolausMaintainsBuy
Sep 2017NeedhamDowngradesBuyHold

View More Analyst Ratings for BRKS
View the Latest Analyst Ratings

Posted-In: Patrick Ho StifelAnalyst Color Upgrades Analyst Ratings

 

Related Articles (BRKS)

View Comments and Join the Discussion!